Revealing therapeutic leads
"The precision of our metagenomic analysis reveals a world of untapped opportunity."
Dr Lutz Krause Head of Data Mining & Artificial Intelligence
Our Therapeutic programs
Microba has two major therapeutic programs underway using insights from our leading analysis platform and our unique approach to genome-directed isolation.
|Inflammatory Bowel Disease||Pre-clinical||Phase 1||-|
|Immuno-Oncology Neoadjuvant Therapy||Discovery||Pre-clinical||-|